- Home
- SCYX vs PVL Comparison
SCYX vs PVL Comparison
Compare SCYX & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- PVL
- Stock Information
- Founded
- SCYX 1999
- PVL 2011
- Country
- SCYX United States
- PVL United States
- Employees
- SCYX N/A
- PVL N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- PVL Oil & Gas Production
- Sector
- SCYX Health Care
- PVL Energy
- Exchange
- SCYX Nasdaq
- PVL Nasdaq
- Market Cap
- SCYX 40.9M
- PVL 45.5M
- IPO Year
- SCYX 2014
- PVL N/A
- Fundamental
- Price
- SCYX $1.03
- PVL $1.55
- Analyst Decision
- SCYX Buy
- PVL
- Analyst Count
- SCYX 1
- PVL 0
- Target Price
- SCYX N/A
- PVL N/A
- AVG Volume (30 Days)
- SCYX 135.5K
- PVL 61.4K
- Earning Date
- SCYX 03-12-2025
- PVL 01-01-0001
- Dividend Yield
- SCYX N/A
- PVL 6.03%
- EPS Growth
- SCYX N/A
- PVL N/A
- EPS
- SCYX N/A
- PVL 0.09
- Revenue
- SCYX $3,746,000.00
- PVL $4,339,313.00
- Revenue This Year
- SCYX $1,541.00
- PVL N/A
- Revenue Next Year
- SCYX $111.43
- PVL N/A
- P/E Ratio
- SCYX N/A
- PVL $18.25
- Revenue Growth
- SCYX N/A
- PVL N/A
- 52 Week Low
- SCYX $0.82
- PVL $1.03
- 52 Week High
- SCYX $3.07
- PVL $1.96
- Technical
- Relative Strength Index (RSI)
- SCYX 50.55
- PVL 58.59
- Support Level
- SCYX $1.00
- PVL $1.47
- Resistance Level
- SCYX $1.06
- PVL $1.57
- Average True Range (ATR)
- SCYX 0.07
- PVL 0.04
- MACD
- SCYX 0.02
- PVL 0.00
- Stochastic Oscillator
- SCYX 63.30
- PVL 63.46
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production the sale of oil and natural gas production from primarily non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.